Check out the latest cell and gene therapy sector insights from Alliance for Regenerative Medicine! Their report for Q3 of 2024 deep dives into data about the ongoing clinical trials, therapeutic developers, and total sector investment.
ARM’s Q3 2024 cell and gene therapy sector data is now available! Dive in to view our figures highlighting clinical trials, the number of therapeutic developers, and total sector investment. One new trend to highlight: 📈 Sector investment through Q3 2024 has now surpassed total sector investment in all of 2023 View the complete data on our website. ➡️ https://lnkd.in/ebVuvmKK
